S&P 500   0.56 (+5.04%)
DOW   0.56 (+5.04%)
QQQ   269.38 (+1.35%)
AAPL   435.75 (+2.52%)
MSFT   216.54 (+5.62%)
FB   251.96 (-0.67%)
GOOGL   1,482.76 (-0.35%)
AMZN   3,111.89 (-1.67%)
NVDA   440.41 (+3.73%)
CGC   19.06 (+4.27%)
BABA   257.94 (+2.76%)
TSLA   1,485.00 (+3.79%)
MU   50.39 (+0.68%)
GE   6.11 (+0.66%)
AMD   77.67 (+0.31%)
T   29.62 (+0.14%)
F   6.69 (+1.21%)
ACB   10.42 (+2.26%)
GILD   71.73 (+3.16%)
NFLX   498.62 (+1.99%)
DIS   116.35 (-0.50%)
BAC   24.99 (+0.44%)
BA   162.27 (+2.70%)
S&P 500   0.56 (+5.04%)
DOW   0.56 (+5.04%)
QQQ   269.38 (+1.35%)
AAPL   435.75 (+2.52%)
MSFT   216.54 (+5.62%)
FB   251.96 (-0.67%)
GOOGL   1,482.76 (-0.35%)
AMZN   3,111.89 (-1.67%)
NVDA   440.41 (+3.73%)
CGC   19.06 (+4.27%)
BABA   257.94 (+2.76%)
TSLA   1,485.00 (+3.79%)
MU   50.39 (+0.68%)
GE   6.11 (+0.66%)
AMD   77.67 (+0.31%)
T   29.62 (+0.14%)
F   6.69 (+1.21%)
ACB   10.42 (+2.26%)
GILD   71.73 (+3.16%)
NFLX   498.62 (+1.99%)
DIS   116.35 (-0.50%)
BAC   24.99 (+0.44%)
BA   162.27 (+2.70%)
S&P 500   0.56 (+5.04%)
DOW   0.56 (+5.04%)
QQQ   269.38 (+1.35%)
AAPL   435.75 (+2.52%)
MSFT   216.54 (+5.62%)
FB   251.96 (-0.67%)
GOOGL   1,482.76 (-0.35%)
AMZN   3,111.89 (-1.67%)
NVDA   440.41 (+3.73%)
CGC   19.06 (+4.27%)
BABA   257.94 (+2.76%)
TSLA   1,485.00 (+3.79%)
MU   50.39 (+0.68%)
GE   6.11 (+0.66%)
AMD   77.67 (+0.31%)
T   29.62 (+0.14%)
F   6.69 (+1.21%)
ACB   10.42 (+2.26%)
GILD   71.73 (+3.16%)
NFLX   498.62 (+1.99%)
DIS   116.35 (-0.50%)
BAC   24.99 (+0.44%)
BA   162.27 (+2.70%)
S&P 500   0.56 (+5.04%)
DOW   0.56 (+5.04%)
QQQ   269.38 (+1.35%)
AAPL   435.75 (+2.52%)
MSFT   216.54 (+5.62%)
FB   251.96 (-0.67%)
GOOGL   1,482.76 (-0.35%)
AMZN   3,111.89 (-1.67%)
NVDA   440.41 (+3.73%)
CGC   19.06 (+4.27%)
BABA   257.94 (+2.76%)
TSLA   1,485.00 (+3.79%)
MU   50.39 (+0.68%)
GE   6.11 (+0.66%)
AMD   77.67 (+0.31%)
T   29.62 (+0.14%)
F   6.69 (+1.21%)
ACB   10.42 (+2.26%)
GILD   71.73 (+3.16%)
NFLX   498.62 (+1.99%)
DIS   116.35 (-0.50%)
BAC   24.99 (+0.44%)
BA   162.27 (+2.70%)
Log in

NYSE:ELOXSenesco Technologies Stock Price, Forecast & News

$3.02
+0.23 (+8.24 %)
(As of 08/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$2.80
Now: $3.02
$3.06
50-Day Range
$2.73
MA: $3.01
$3.53
52-Week Range
$1.44
Now: $3.02
$8.16
Volume90,732 shs
Average Volume150,655 shs
Market Capitalization$121.19 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel therapeutics for the treatment of rare and ultra-rare premature stop codon diseases. Its lead program is ELX-02, which is in Phase I clinical trial, which focuses on the treatment of cystic fibrosis and cystinosis patients with diagnosed nonsense mutations. The company was founded in 2013 and is headquartered in Waltham, Massachusetts.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone781-577-5300

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Market Cap$121.19 million
Next Earnings Date8/6/2020 (Confirmed)
OptionableNot Optionable
$3.02
+0.23 (+8.24 %)
(As of 08/3/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ELOX News and Ratings via Email

Sign-up to receive the latest news and ratings for ELOX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Senesco Technologies (NYSE:ELOX) Frequently Asked Questions

How has Senesco Technologies' stock been impacted by COVID-19 (Coronavirus)?

Senesco Technologies' stock was trading at $2.88 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ELOX shares have increased by 4.9% and is now trading at $3.02.
View which stocks have been most impacted by Coronavirus
.

When is Senesco Technologies' next earnings date?

Senesco Technologies is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020.
View our earnings forecast for Senesco Technologies
.

How can I listen to Senesco Technologies' earnings call?

Senesco Technologies will be holding an earnings conference call on Thursday, August 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Senesco Technologies' earnings last quarter?

Senesco Technologies Inc. (NYSE:ELOX) released its quarterly earnings results on Thursday, May, 7th. The company reported ($0.35) earnings per share for the quarter, missing the consensus estimate of ($0.29) by $0.06.
View Senesco Technologies' earnings history
.

Has Senesco Technologies been receiving favorable news coverage?

News headlines about ELOX stock have been trending negative recently, according to InfoTrie. The research group scores the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Senesco Technologies earned a news sentiment score of -2.9 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the immediate future.
View the latest news about Senesco Technologies
.

Who are some of Senesco Technologies' key competitors?

What other stocks do shareholders of Senesco Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Senesco Technologies investors own include Aclaris Therapeutics (ACRS), Acorda Therapeutics (ACOR), Achieve Life Sciences (ACHV), ADMA Biologics (ADMA), Agenus (AGEN), AIM ImmunoTech (AIM), Accuray (ARAY), Cidara Therapeutics (CDTX), Canopy Growth (CGC) and Celldex Therapeutics (CLDX).

Who are Senesco Technologies' key executives?

Senesco Technologies' management team includes the following people:
  • Mr. Robert E. Ward, Chairman & CEO (Age 61)
  • Dr. Silvia Noiman, Founder & Director (Age 62)
  • Mr. Gregory L. Weaver CPA, M.B.A., Chief Financial Officer (Age 62)
  • Dr. Gregory Williams, COO & Interim Chief Medical Officer (Age 59)
  • Ms. Barbara Ryan, Investor Relations Officer

What is Senesco Technologies' stock symbol?

Senesco Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "ELOX."

How do I buy shares of Senesco Technologies?

Shares of ELOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Senesco Technologies' stock price today?

One share of ELOX stock can currently be purchased for approximately $3.02.

How big of a company is Senesco Technologies?

Senesco Technologies has a market capitalization of $121.19 million.

What is Senesco Technologies' official website?

The official website for Senesco Technologies is www.eloxxpharma.com.

How can I contact Senesco Technologies?

The company can be reached via phone at 781-577-5300.

This page was last updated on 8/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.